Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects. - Wikidata - awgldk - TriplyDB

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.

http://www.wikidata.org/entity/Q34007510

about

The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.Allopregnanolone and neurogenesis in the nigrostriatal tract.Glycine and GABA(A) ultra-sensitive ethanol receptors as novel tools for alcohol and brain research.Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.Neuroprotective actions of neurosteroids Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.Pregnenolone sulfate as a modulator of synaptic plasticity.Sex and the development of Alzheimer's disease.Neurosteroids as regenerative agents in the brain: therapeutic implications.Advances in neurosteroids: role in clinical practice.Potential of neural stem cell-based therapies for Alzheimer's disease.Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism.Allopregnanolone attenuates Aβ25-35-induced neurotoxicity in PC12 cells by reducing oxidative stress.Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease Emerging Therapeutic Role of PPAR-α in Cognition and Emotions

P2860

Q24564068-49B1FEF5-2AA3-43BA-A07E-1D12C7EC7E74 Q27334826-61E90537-2AC4-4374-83E2-35981E0671B4 Q28740634-CCB8EAC0-B318-4F29-89EC-4E9A549E3582 Q33972726-66936F0A-7A21-4F12-B7B2-009283B6D140 Q34033021-587DA175-1A9B-4D59-A66B-838C6DF07827 Q34573962-AA47A5BF-8F1F-4BE3-B548-D113AD3AE5D6 Q35597044-86F46B76-A9B6-4809-8DB9-FD2A3F635FB0 Q35947523-C4456E2B-36B3-496D-BB75-8BFA7568D25F Q35971511-1544332A-9515-4C35-9E30-E0E9733745D8 Q35972117-6FCCF3AD-6D62-490F-91E1-F2ABBE595F7E Q36224315-55677A31-4211-4728-AA45-5922D2F3074A Q37432182-659E1C6F-CAB3-4E97-9A46-630D43FFAF8D Q38084436-31330AB4-D041-4615-AEDC-17D120406980 Q38121153-82840C4B-D7C3-44A7-8FD0-E4F255EA8D6F Q38324410-C1B3BF51-2AC6-4433-B936-0D0E72283E7D Q38571198-B66B3FCA-AA8D-47E3-8AA9-69E0D46801D8 Q41549578-84A262E5-D54E-40E3-A0B4-9A8CFBAD0FE5 Q43209931-9BB7CF3F-B57F-470C-ADDA-8B1D4CF24CAB Q50632749-8E12B118-9458-465A-AD2E-BFC65B59F765 Q57817974-7CD24B8B-8BAC-4E55-86A2-818B7F92C2E5 Q57818280-610C4690-6E25-4B03-9FB8-5E34ABDBA500

P2860

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.

http://www.wikidata.org/entity/Q34007510

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Allopregnanolone levels are re ...... ively intact control subjects.

@ast

Allopregnanolone levels are re ...... ively intact control subjects.

@en

Allopregnanolone levels are re ...... ively intact control subjects.

@nl

type

label

Allopregnanolone levels are re ...... ively intact control subjects.

@ast

Allopregnanolone levels are re ...... ively intact control subjects.

@en

Allopregnanolone levels are re ...... ively intact control subjects.

@nl

prefLabel

Allopregnanolone levels are re ...... ively intact control subjects.

@ast

Allopregnanolone levels are re ...... ively intact control subjects.

@en

Allopregnanolone levels are re ...... ively intact control subjects.

@nl

P1433

Q34007510-CBC035E2-4E99-4B5B-B6C1-D6B58DCE9BA1

P1476

Q34007510-CFBB88FF-A40D-48C8-A27F-627F13DFEFF3

P2093

Q34007510-2F3C13DA-5CD3-41B0-A88D-094093D28166

Q34007510-30A886D7-3C63-4F25-8F8E-39BCA97C570C

Q34007510-3B77D99C-53C7-44FF-B6CB-E92E83D60701

Q34007510-67D428B1-CB5E-419C-A08C-556167728786

Q34007510-75627FD8-653C-4D22-A6D1-914DA9482EF9

Q34007510-75B4ED1F-326A-4F69-9A0C-A57C1180E880

Q34007510-7C1CE016-D829-4EFD-93C2-C198DBF64CF5

Q34007510-9238EE5A-57EC-40F3-91EF-4E45766E8BF3

Q34007510-AA244272-8FDA-4328-9063-589675011452

Q34007510-C8B6AC2D-FAE2-4C84-8518-80F21DEE741F

P2860

Q34007510-00150854-B9F5-4903-884A-8931AD2CC4E2

Q34007510-05918906-66C9-41AF-BA7B-3239D6E2FFA5

Q34007510-05C2B10C-7549-4978-9CF7-60C65384EA48

Q34007510-07FDFBEA-2C5A-4D61-89AC-58CFE8B504F5

Q34007510-163BCE62-0555-4C23-A501-70317AC41821

Q34007510-1793B44E-F264-42F1-9EBA-E05FAF625054

Q34007510-19791161-DF4D-4814-906E-D79042A6D5F3

Q34007510-1A0B93D1-1CE5-424D-801B-418564F7E5CD

Q34007510-1A564E3B-46B2-446E-BAE1-C588DFC7B90A

Q34007510-1AD8E887-46B0-446D-9DAF-713C397C8951

P304

Q34007510-D25BE0D5-DF3E-42A4-BE7A-CD95D5A9B2F5

P31

Q34007510-0CA8DCC6-7131-4020-BB16-B4BAC76D92E7

P356

Q34007510-A1840B20-4A63-4CEE-A0ED-DFD25BC50CD3

P407

Q34007510-D607A717-6867-4218-AE59-44A6D2B85E67

P433

Q34007510-B1E03A3D-6E5B-4304-A2FE-33FAFF287324

P478

Q34007510-217E46F5-3446-42EF-B785-1C71D5F35931

P50

Q34007510-FA730BEC-E878-4FB2-A48A-8F2B6454EE3A

P577

Q34007510-24145A21-2A03-4195-B92D-8928BAD3A53E

P5875

Q34007510-C09DDACD-D724-49CC-89C9-42AE1A1BC941

P698

Q34007510-8538B12B-90E4-417D-B3CC-7AE01C8BE4A0

P921

Q34007510-9AFE57B8-427C-4033-98A4-D5E0EE750EF2

P932

Q34007510-87EF8FBE-8525-44A6-A2CB-3324BF53FFD1

P356

J.BBALIP.2010.05.006

P1433

Biochimica et Biophysica Acta

P1476

Allopregnanolone levels are re ...... tively intact control subjects

@en

P2093

Christine E Marx

http://www.w3.org/2001/XMLSchema#string

Christine M Hulette

http://www.w3.org/2001/XMLSchema#string

Dan G Blazer

http://www.w3.org/2001/XMLSchema#string

David C Steffens

http://www.w3.org/2001/XMLSchema#string

Jason D Kilts

http://www.w3.org/2001/XMLSchema#string

Jennifer C Naylor

http://www.w3.org/2001/XMLSchema#string

Jennifer L Strauss

http://www.w3.org/2001/XMLSchema#string

John F Ervin

http://www.w3.org/2001/XMLSchema#string

Lawrence J Shampine

http://www.w3.org/2001/XMLSchema#string

Mark W Massing

http://www.w3.org/2001/XMLSchema#string

P2860

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Alzheimer's disease: the cholesterol connection

The pharmacology of neurosteroidogenesis

The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression

P304

951-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBALIP.2010.05.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

1801

http://www.w3.org/2001/XMLSchema#string

P50

Nagy A. Youssef

P577

2010-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44616852

http://www.w3.org/2001/XMLSchema#string

P698

20488256

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2907131

http://www.w3.org/2001/XMLSchema#string